_id
69148a07ccc777a4e85d98bf
Ticker
PANC
Name
Panacos Pharmaceuticals Inc
Exchange
OTCCE
Address
134 Coolidge Avenue, Watertown, MA, United States, 02472
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
Description
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-06T08:50:59.876Z
Image
data:image/webp;base64,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
Ipo Date
1998-06-10T00:00:00.000Z
Market Cap
321841
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2008-09-30
Revenue
24000
Cost Of Revenue
7498000
Gross Profit
24000
Operating Expenses
7595000
Operating Income
-7571000
Interest Expense
771000
Pretax Income
-8152000
Net Income
-8152000
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
0
EBITDA
-
Operating Margin
-31545.833333333332
Total Other Income Expense Net
-581000
Cash
21368000
Short Term Investments
5520000
Receivables
101000
Inventories
-
Total Current Assets
27516000
Property Plant Equipment
843000
Total Assets
29738000
Payables
1172000
Short Term Debt
6991000
Long Term Debt
11098000
Total Liabilities
24466000
Equity
5272000
Bs_currency_symbol
USD
Depreciation
97000
Change In Working Capital
-
Cash From Operations
-7799000
Capital Expenditures
3000
Cash From Investing
3790000
Cash From Financing
-1298000
Net Change In Cash
-5307000
Cf_currency_symbol
USD
PE
-
PB
-
ROE
-154.62822458270108
ROA
-27.41273791109019
FCF
-7802000
Fcf Percent
-325.0833333333333
Piotroski FScore
1
Health Score
18
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
3
Net Net Investing Score
6.5
Quality Investing Score
1
Value Investing Score
1
Quarters > 0 > quarter
2008-09-30
Quarters > 0 > income Statement > revenue
24000
Quarters > 0 > income Statement > cost Of Revenue
7498000
Quarters > 0 > income Statement > gross Profit
24000
Quarters > 0 > income Statement > operating Expenses
7595000
Quarters > 0 > income Statement > operating Income
-7571000
Quarters > 0 > income Statement > interest Expense
771000
Quarters > 0 > income Statement > pretax Income
-8152000
Quarters > 0 > income Statement > net Income
-8152000
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-31545.833333333332
Quarters > 0 > income Statement > total Other Income Expense Net
-581000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
21368000
Quarters > 0 > balance Sheet > short Term Investments
5520000
Quarters > 0 > balance Sheet > receivables
101000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
27516000
Quarters > 0 > balance Sheet > property Plant Equipment
843000
Quarters > 0 > balance Sheet > total Assets
29738000
Quarters > 0 > balance Sheet > payables
1172000
Quarters > 0 > balance Sheet > short Term Debt
6991000
Quarters > 0 > balance Sheet > long Term Debt
11098000
Quarters > 0 > balance Sheet > total Liabilities
24466000
Quarters > 0 > balance Sheet > equity
5272000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-8152000
Quarters > 0 > cash Flow > depreciation
97000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-7799000
Quarters > 0 > cash Flow > capital Expenditures
3000
Quarters > 0 > cash Flow > cash From Investing
3790000
Quarters > 0 > cash Flow > cash From Financing
-1298000
Quarters > 0 > cash Flow > net Change In Cash
-5307000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-154.62822458270108
Quarters > 0 > ratios > ROA
-27.41273791109019
Quarters > 0 > ratios > FCF
-7802000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-325.0833333333333
Quarters > 0 > health Score
18
Quarters > 1 > quarter
2008-06-30
Quarters > 1 > income Statement > revenue
18000
Quarters > 1 > income Statement > cost Of Revenue
9138000
Quarters > 1 > income Statement > gross Profit
18000
Quarters > 1 > income Statement > operating Expenses
9235000
Quarters > 1 > income Statement > operating Income
-9217000
Quarters > 1 > income Statement > interest Expense
777000
Quarters > 1 > income Statement > pretax Income
-9742000
Quarters > 1 > income Statement > net Income
-9742000
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-51205.555555555555
Quarters > 1 > income Statement > total Other Income Expense Net
-525000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
26675000
Quarters > 1 > balance Sheet > short Term Investments
9211000
Quarters > 1 > balance Sheet > receivables
81000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
36718000
Quarters > 1 > balance Sheet > property Plant Equipment
937000
Quarters > 1 > balance Sheet > total Assets
39090000
Quarters > 1 > balance Sheet > payables
1832000
Quarters > 1 > balance Sheet > short Term Debt
6277000
Quarters > 1 > balance Sheet > long Term Debt
12941000
Quarters > 1 > balance Sheet > total Liabilities
26476000
Quarters > 1 > balance Sheet > equity
12614000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-9742000
Quarters > 1 > cash Flow > depreciation
97000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-7770000
Quarters > 1 > cash Flow > capital Expenditures
31000
Quarters > 1 > cash Flow > cash From Investing
2011000
Quarters > 1 > cash Flow > cash From Financing
-116000
Quarters > 1 > cash Flow > net Change In Cash
-5875000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-77.2316473759315
Quarters > 1 > ratios > ROA
-24.921974929649526
Quarters > 1 > ratios > FCF
-7801000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-433.3888888888889
Quarters > 1 > health Score
22
Quarters > 2 > quarter
2008-03-31
Quarters > 2 > income Statement > revenue
35000
Quarters > 2 > income Statement > cost Of Revenue
8120000
Quarters > 2 > income Statement > gross Profit
35000
Quarters > 2 > income Statement > operating Expenses
8215000
Quarters > 2 > income Statement > operating Income
-8180000
Quarters > 2 > income Statement > interest Expense
772000
Quarters > 2 > income Statement > pretax Income
-8512000
Quarters > 2 > income Statement > net Income
-8512000
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-23371.428571428572
Quarters > 2 > income Statement > total Other Income Expense Net
-332000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
32550000
Quarters > 2 > balance Sheet > short Term Investments
11063000
Quarters > 2 > balance Sheet > receivables
120000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
44826000
Quarters > 2 > balance Sheet > property Plant Equipment
1003000
Quarters > 2 > balance Sheet > total Assets
47344000
Quarters > 2 > balance Sheet > payables
2764000
Quarters > 2 > balance Sheet > short Term Debt
4469000
Quarters > 2 > balance Sheet > long Term Debt
14717000
Quarters > 2 > balance Sheet > total Liabilities
25868000
Quarters > 2 > balance Sheet > equity
21476000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-8512000
Quarters > 2 > cash Flow > depreciation
95000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-8453000
Quarters > 2 > cash Flow > capital Expenditures
47000
Quarters > 2 > cash Flow > cash From Investing
3267000
Quarters > 2 > cash Flow > cash From Financing
-129000
Quarters > 2 > cash Flow > net Change In Cash
-5315000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-39.63494132985658
Quarters > 2 > ratios > ROA
-17.979046975329503
Quarters > 2 > ratios > FCF
-8500000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-242.85714285714286
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2007-12-31
Quarters > 3 > income Statement > revenue
22000
Quarters > 3 > income Statement > cost Of Revenue
9181000
Quarters > 3 > income Statement > gross Profit
22000
Quarters > 3 > income Statement > operating Expenses
9277000
Quarters > 3 > income Statement > operating Income
-9255000
Quarters > 3 > income Statement > interest Expense
763000
Quarters > 3 > income Statement > pretax Income
-9349000
Quarters > 3 > income Statement > net Income
-9349000
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-42068.181818181816
Quarters > 3 > income Statement > total Other Income Expense Net
-94000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
37865000
Quarters > 3 > balance Sheet > short Term Investments
14030000
Quarters > 3 > balance Sheet > receivables
147000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
53098000
Quarters > 3 > balance Sheet > property Plant Equipment
1045000
Quarters > 3 > balance Sheet > total Assets
55710000
Quarters > 3 > balance Sheet > payables
2977000
Quarters > 3 > balance Sheet > short Term Debt
358000
Quarters > 3 > balance Sheet > long Term Debt
18798000
Quarters > 3 > balance Sheet > total Liabilities
26840000
Quarters > 3 > balance Sheet > equity
28870000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-9349000
Quarters > 3 > cash Flow > depreciation
96000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-7125000
Quarters > 3 > cash Flow > capital Expenditures
15000
Quarters > 3 > cash Flow > cash From Investing
1847000
Quarters > 3 > cash Flow > cash From Financing
10353000
Quarters > 3 > cash Flow > net Change In Cash
5075000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-32.38309664011084
Quarters > 3 > ratios > ROA
-16.78154729851014
Quarters > 3 > ratios > FCF
-7140000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-324.54545454545456
Quarters > 3 > health Score
32
Annuals > 0 > quarter
2007-12-31
Annuals > 0 > income Statement > revenue
180000
Annuals > 0 > income Statement > cost Of Revenue
37392000
Annuals > 0 > income Statement > gross Profit
180000
Annuals > 0 > income Statement > operating Expenses
37930000
Annuals > 0 > income Statement > operating Income
-37750000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-37459000
Annuals > 0 > income Statement > net Income
-37459000
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-20972.222222222223
Annuals > 0 > income Statement > total Other Income Expense Net
291000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
37865000
Annuals > 0 > balance Sheet > short Term Investments
14030000
Annuals > 0 > balance Sheet > receivables
147000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
53098000
Annuals > 0 > balance Sheet > property Plant Equipment
1045000
Annuals > 0 > balance Sheet > total Assets
55710000
Annuals > 0 > balance Sheet > payables
2977000
Annuals > 0 > balance Sheet > short Term Debt
358000
Annuals > 0 > balance Sheet > long Term Debt
18798000
Annuals > 0 > balance Sheet > total Liabilities
26840000
Annuals > 0 > balance Sheet > equity
28870000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-37459000
Annuals > 0 > cash Flow > depreciation
538000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-31035000
Annuals > 0 > cash Flow > capital Expenditures
48000
Annuals > 0 > cash Flow > cash From Investing
15150000
Annuals > 0 > cash Flow > cash From Financing
20610000
Annuals > 0 > cash Flow > net Change In Cash
4725000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-129.7506061655698
Annuals > 0 > ratios > ROA
-67.23927481601149
Annuals > 0 > ratios > FCF
-31083000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-172.68333333333334
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2006-12-31
Annuals > 1 > income Statement > revenue
284000
Annuals > 1 > income Statement > cost Of Revenue
35328000
Annuals > 1 > income Statement > gross Profit
284000
Annuals > 1 > income Statement > operating Expenses
36579000
Annuals > 1 > income Statement > operating Income
-36295000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-38110000
Annuals > 1 > income Statement > net Income
-38110000
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-12779.929577464789
Annuals > 1 > income Statement > total Other Income Expense Net
-1815000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
33140000
Annuals > 1 > balance Sheet > short Term Investments
27626000
Annuals > 1 > balance Sheet > receivables
66000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
62977000
Annuals > 1 > balance Sheet > property Plant Equipment
2122000
Annuals > 1 > balance Sheet > total Assets
65653000
Annuals > 1 > balance Sheet > payables
3226000
Annuals > 1 > balance Sheet > short Term Debt
361000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6969000
Annuals > 1 > balance Sheet > equity
58684000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-38110000
Annuals > 1 > cash Flow > depreciation
751000
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-29630000
Annuals > 1 > cash Flow > capital Expenditures
519000
Annuals > 1 > cash Flow > cash From Investing
-26183000
Annuals > 1 > cash Flow > cash From Financing
1815000
Annuals > 1 > cash Flow > net Change In Cash
-53998000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-64.94104014722922
Annuals > 1 > ratios > ROA
-58.047613970420244
Annuals > 1 > ratios > FCF
-30149000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-106.15845070422536
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2005-12-31
Annuals > 2 > income Statement > revenue
1049000
Annuals > 2 > income Statement > cost Of Revenue
24815000
Annuals > 2 > income Statement > gross Profit
1049000
Annuals > 2 > income Statement > operating Expenses
25443000
Annuals > 2 > income Statement > operating Income
-24394000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-59078000
Annuals > 2 > income Statement > net Income
-59078000
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-2325.452812202097
Annuals > 2 > income Statement > total Other Income Expense Net
-34684000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
87138000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
389000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
88612000
Annuals > 2 > balance Sheet > property Plant Equipment
2354000
Annuals > 2 > balance Sheet > total Assets
91571000
Annuals > 2 > balance Sheet > payables
1912000
Annuals > 2 > balance Sheet > short Term Debt
207000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
5970000
Annuals > 2 > balance Sheet > equity
85601000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-59078000
Annuals > 2 > cash Flow > depreciation
628000
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-21646000
Annuals > 2 > cash Flow > capital Expenditures
150000
Annuals > 2 > cash Flow > cash From Investing
406000
Annuals > 2 > cash Flow > cash From Financing
103499000
Annuals > 2 > cash Flow > net Change In Cash
82259000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-69.01554888377473
Annuals > 2 > ratios > ROA
-64.51605857749723
Annuals > 2 > ratios > FCF
-21796000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-20.777883698760725
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2004-12-31
Annuals > 3 > income Statement > revenue
1337000
Annuals > 3 > income Statement > cost Of Revenue
14471000
Annuals > 3 > income Statement > gross Profit
1337000
Annuals > 3 > income Statement > operating Expenses
10906000
Annuals > 3 > income Statement > operating Income
-9569000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-12038000
Annuals > 3 > income Statement > net Income
-12038000
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-715.7068062827225
Annuals > 3 > income Statement > total Other Income Expense Net
-2469000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4879000
Annuals > 3 > balance Sheet > short Term Investments
250000
Annuals > 3 > balance Sheet > receivables
280000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
5221000
Annuals > 3 > balance Sheet > property Plant Equipment
310000
Annuals > 3 > balance Sheet > total Assets
6331000
Annuals > 3 > balance Sheet > payables
472000
Annuals > 3 > balance Sheet > short Term Debt
122000
Annuals > 3 > balance Sheet > long Term Debt
30000
Annuals > 3 > balance Sheet > total Liabilities
2858000
Annuals > 3 > balance Sheet > equity
-26446000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-12038000
Annuals > 3 > cash Flow > depreciation
112000
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-9773000
Annuals > 3 > cash Flow > capital Expenditures
76000
Annuals > 3 > cash Flow > cash From Investing
-527000
Annuals > 3 > cash Flow > cash From Financing
14702000
Annuals > 3 > cash Flow > net Change In Cash
4402000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
45.519171141193375
Annuals > 3 > ratios > ROA
-190.14373716632446
Annuals > 3 > ratios > FCF
-9849000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-7.366492146596858
Annuals > 3 > health Score
41
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
-154.62822458270108
Profitability > metrics > ROA
-29.626399185928186
Profitability > metrics > Net Margin
-339.6666666666667
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
4.640743550834598
Risk > metrics > Interest Coverage
-9.819714656290532
Risk > final Score
-33
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.370819551635428
Liquidity > metrics > Quick Ratio
3.370819551635428
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-29
Prev Risks > 1
-12
Prev Risks > 2
-1
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:22:14.033Z
Earnings History > 0 > period
2008-09-30
Earnings History > 0 > report Date
2008-09-30
Earnings History > 0 > date
2008-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.15
Earnings History > 0 > eps Estimate
-0.195
Earnings History > 0 > eps Difference
0.045
Earnings History > 0 > surprise Percent
23.0769
Earnings History > 1 > period
2008-06-30
Earnings History > 1 > report Date
2008-06-30
Earnings History > 1 > date
2008-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.18
Earnings History > 1 > eps Estimate
-0.18
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
0
Earnings History > 2 > period
2008-03-31
Earnings History > 2 > report Date
2008-03-31
Earnings History > 2 > date
2008-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.16
Earnings History > 2 > eps Estimate
-0.186
Earnings History > 2 > eps Difference
0.026
Earnings History > 2 > surprise Percent
13.9785
Earnings History > 3 > period
2007-12-31
Earnings History > 3 > report Date
2007-12-31
Earnings History > 3 > date
2007-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.17
Earnings History > 3 > eps Estimate
-0.196
Earnings History > 3 > eps Difference
0.026
Earnings History > 3 > surprise Percent
13.2653
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AStevia leaf extract has potential as anticancer treatment, researchers find - Medical Xpress
7/18/2025
Stevia leaf extract has potential as anticancer treatment, researchers find Medical Xpress
Read more →Management of pancreatitis in dogs and the role of PANOQUELL®-CA1 (fuzapladib sodium for injection) DVM360
Read more →Showing 2 of 4
(Last Updated 2008-09-30)
Health Score
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Panacos Pharmaceuticals Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2008-09-30
EPS Actual
-0.15
EPS Estimate
-0.195
EPS Difference
0.045
Surprise Percent
23.0769%
(Last Updated 2008-09-30)
(Last Updated 2008-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2008-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2008-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.